Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Etanidazole

Drug Profile

Etanidazole

Alternative Names: DUP 453; NSC 301467; NSC 314055; Radinyl; SP 2508; SR 2508

Latest Information Update: 12 Jul 2002

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Cancer Institute (USA); Nonindustrial source; SRI International
  • Developer Bristol-Myers Squibb; Nonindustrial source; SRI International
  • Class Antineoplastics; Chemosensitisers; Nitroimidazoles; Radiosensitisers; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 18 Jan 2000 Roberts Pharmaceutical has been merged into Shire Pharmaceuticals Group
  • 10 Sep 1998 A study in patients with head and neck cancer has been added to the therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top